EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program

JoAnn V Pinkerton, James A Simon, Nick Panay, Rossella E Nappi, Donal J Brennan, Gilbert Donders, Claudio N Soares, Pauline Maki, Cecilia Caetano, Claudia Haberland, Kaisa Laapas, Lineke Zuurman und 1 weitere

Maturitas · 2026

DOI: 10.1016/j.maturitas.2026.109075 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Maturitas, 2026. Verfasst von JoAnn V Pinkerton und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division Midlife Health, University of Virginia Health, Charlottesville, VA, United States. Electronic addre…. Hauptthemen laut MEDLINE: Hot Flashes, Menopause, Sleep Wake Disorders, Neurokinin-1 Receptor Antagonists. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hot FlashesMenopauseSleep Wake DisordersNeurokinin-1 Receptor AntagonistsHumansFemaleVasomotor SystemRandomized Controlled Trials as TopicBreast NeoplasmsEstradiolProgesterone

Stichwörter der Autor:innen

ElinzanetantHot flashesMenopauseNeurokinin-1,3 receptor antagonistSleep disturbanceVasomotor symptoms

Substanzen

Neurokinin-1 Receptor AntagonistsTX-001HREstradiolProgesterone

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Division Midlife Health, University of Virginia Health, Charlottesville, VA, United States. Electronic address: JVP9U@uvahealth.org.
  • George Washington University, IntimMedicine Specialists, Washington, DC, United States. Electronic address: jsimon@intimmedicine.com.
  • Queen Charlotte's & Chelsea Hospital, Imperial College, London, United Kingdom. Electronic address: nickpanay@msn.com.
  • Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy; Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS San Matteo Foundation,…
  • UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland. Electronic address: donal.brennan@ucd.ie.
  • Femicare, Clinical Research for Women, Tienen, Belgium. Electronic address: gilbert.donders@gmail.com.

Förderung

  • Bayer

Zitieren

APA

Pinkerton, J. V., Simon, J. A., Panay, N., Nappi, R. E., Brennan, D. J., Donders, G., Soares, C. N., Maki, P., Caetano, C., Haberland, C., Laapas, K., Zuurman, L., & Cardoso, F. (2026). Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program. Maturitas. https://doi.org/10.1016/j.maturitas.2026.109075

Vancouver

Pinkerton JV, Simon JA, Panay N, Nappi RE, Brennan DJ, Donders G, et al. Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program. Maturitas. 2026. doi:10.1016/j.maturitas.2026.109075

BibTeX
@article{Pinkerton2026,
  author = {Pinkerton, JoAnn V and Simon, James A and Panay, Nick and Nappi, Rossella E and Brennan, Donal J and Donders, Gilbert and Soares, Claudio N and Maki, Pauline and Caetano, Cecilia and Haberland, Claudia and Laapas, Kaisa and Zuurman, Lineke and Cardoso, Fatima},
  title = {Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program},
  journal = {Maturitas},
  year = {2026},
  doi = {10.1016/j.maturitas.2026.109075}
}
Kostenlos starten →